Letters

I would like to offer comments to correct the record on statements given by Senator Bill Cassidy (R-LA) at the October 7, 2015, hearing on the National Institutes of Health fiscal year 2016 budget. Several of his comments to the committee and NIH Director Francis Collins were incorrect or misleading. If his erroneous statements about AIDS research funding at the NIH are mistaken for fact, we will set a dangerous course for current and future research being conducted at the agency and undermine the prioritization process under way at the Office of AIDS Research (OAR).

150 organizations called on six pharmaceutical companies to continue funding the vital D:A:D study. 150 HIV Organizations Urge Continuation of D:A:D Study

Letter from TAG and others asking for withdrawal of mandatory quarantine requirement for entering the US through Newark and JFK airports who have had direct contact with individuals with Ebola Virus Disease in Guinea, Liberia, and Sierra Leone.

Letter from TAG and other advocates expressing concerns about proposed Medicaid criteria that will limit access to sofosbuvir and other lifesaving hepatitis C medications.

Letter asking to speak to key staff at Novartis to discuss its support of the clinical research required to more fully understand the efficacy of Menveo in adolescents and adults living with HIV.